Theriva Biologics logo

Theriva Biologics share price today

(TOVX)

Theriva Biologics share price is $1.73 & ₹148.45 as on 7 Jan 2025, 2.30 'hrs' IST

$1.73

0.14

(8.81%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Theriva Biologics share price in Dollar and Rupees. Guide to invest in Theriva Biologics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Theriva Biologics, along with analyst recommendations, forecasts, and comprehensive financials.

Theriva Biologics share price movements

  • Today's Low: $1.62
    Today's High: $1.76

    Day's Volatility :7.96%

  • 52 Weeks Low: $1.14
    52 Weeks High: $17.11

    52 Weeks Volatility :93.34%

Theriva Biologics Returns

PeriodTheriva Biologics IncIndex (Russel 2000)
3 Months
3.25%
0.0%
6 Months
-76.0%
0.0%
1 Year
-86.17%
0.0%
3 Years
-93.83%
-19.8%

Theriva Biologics Key Statistics

in dollars & INR

Previous Close
$1.59
Open
$1.6
Today's High
$1.7601
Today's Low
$1.62
Market Capitalization
$4.9M
Today's Volume
$116.4K
52 Week High
$17.1125
52 Week Low
$1.14
Revenue TTM
$0.0
EBITDA
$-21.4M
Earnings Per Share (EPS)
$-32.59
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-59.06%

How to invest in Theriva Biologics from India?

It is very easy for Indian residents to invest directly in Theriva Biologics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Theriva Biologics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Theriva Biologics or TOVX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Theriva Biologics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Theriva Biologics shares which would translate to 0.496 fractional shares of Theriva Biologics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Theriva Biologics, in just a few clicks!

Returns in Theriva Biologics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Theriva Biologics investment value today

Current value as on today

₹18,266

Returns

₹81,734

(-81.73%)

Returns from Theriva Biologics Stock

₹84,957 (-84.96%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Theriva Biologics

25%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Theriva Biologics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 25% more investors are searching Theriva Biologics in the last 30 days versus the previous period.

Analyst Recommendation on Theriva Biologics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Theriva Biologics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Theriva Biologics

What analysts predicted

Upside of 5131.21%

Current:

$1.73

Target:

$90.50

Insights on Theriva Biologics

  • Price Movement

    In the last 1 month, TOVX stock has moved up by 25.2%
  • TOVX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 109.6%

Theriva Biologics Technicals Summary

Sell

Neutral

Buy

Theriva Biologics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Theriva Biologics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Theriva Biologics Inc
22.31%
-76.0%
-86.17%
-93.83%
-93.83%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Theriva Biologics Inc
NA
NA
NA
-23.75
-0.59
-0.25
NA
53.89
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Theriva Biologics Inc
Buy
$4.9M
-93.83%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Theriva Biologics

synthetic biologics, inc. (nyse mkt: syn) is a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. the company's lead candidates poised for phase 3 development are: (1) syn-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (ibs-c), and (2) syn-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (iv) beta-lactam antibiotics for the prevention of c. difficile infection (cdi), antibiotic-associated diarrhea (aad) and the emergence of antimicrobial-resistance (amr). the company is also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria (pku).
Organization
Theriva Biologics
Employees
22
CEO
Mr. Steven A. Shallcross CPA
Industry
Miscellaneous

Management People of Theriva Biologics

NameTitle
Mr. Steven A. Shallcross CPA
CEO, CFO, Treasurer, Corporate Secretary & Director
Dr. Vince Wacher Ph.D.
Head of Product & Corporate Development
Dr. Michael Kaleko M.D., Ph.D.
Senior Vice President of Research & Development
Dr. Ramon Alemany Ph.D.
Senior VP of Discovery & Chairman of Scientific Advisory Board

Important FAQs about investing in Theriva Biologics from India :

What is Theriva Biologics share price today?

Theriva Biologics share price today stands at $1.73, Open: $1.60 ; Previous Close: $1.59 ; High: $1.76 ; Low: $1.62 ; 52 Week High: $17.11 ; 52 Week Low: $1.14. The stock opens at $1.60, after a previous close of $1.59. The stock reached a daily high of $1.76 and a low of $1.62, with a 52-week high of $17.11 and a 52-week low of $1.14.

Can Indians buy Theriva Biologics shares?

Yes, Indians can invest in the Theriva Biologics (TOVX) from India.

With INDmoney, you can buy Theriva Biologics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Theriva Biologics at zero transaction cost.

How can I buy Theriva Biologics shares from India?

It is very easy to buy Theriva Biologics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Theriva Biologics be purchased?

Yes, you can buy fractional shares of Theriva Biologics with INDmoney app.

What are the documents required to start investing in Theriva Biologics stocks?

To start investing in Theriva Biologics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Theriva Biologics

Today’s highest price of Theriva Biologics (TOVX) is $1.76.

Today’s lowest price of Theriva Biologics (TOVX) is $1.62.

What is today's market capitalisation of Theriva Biologics

Today's market capitalisation of Theriva Biologics TOVX is 4.9M

What is the 52 Week High and Low Range of Theriva Biologics

  • 52 Week High

    $17.11

  • 52 Week Low

    $1.14

What are the historical returns of Theriva Biologics?

  • 1 Month Returns

    22.31%

  • 3 Months Returns

    -76%

  • 1 Year Returns

    -86.17%

  • 5 Years Returns

    -93.83%

Who is the Chief Executive Officer (CEO) of Theriva Biologics

Mr. Steven A. Shallcross CPA is the current Chief Executive Officer (CEO) of Theriva Biologics.